+ Follow AZITHROMYCIN Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1363612
[Title] => Ditch azithromycin in nongonococcal urethritis?
[Summary] => Recent evidence dictates the need to reassess the roles of doxycycline and azithromycin in treating Chlamydia trachomatis nongonococcal urethritis, according to Dr. Michel Janier.
[DatePublished] => 2014-08-31 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 915186
[Title] => Cases of resistant N. gonorrhoeae seen in San Diego
[Summary] => Neisseria gonorrhoeae cases resistant to azithromycin detected in San Diego led the Centers for Disease Control and Prevention to issue a ”Dear Colleague” letter reminding clinicians to limit use of azithromycin monotherapy to treat uncomplicated rectal and genitourinary infections caused by N. gonorrhoeae.
[DatePublished] => 2013-03-03 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[2] => Array
(
[ArticleID] => 901500
[Title] => Federal STD guidelines address shifting susceptibility
[Summary] => Revised gonorrhea treatment regiment and expanded STD prevention recommendation are key features in updated Sexually Transmitted Disease Control and Prevention.
[DatePublished] => 2013-01-27 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[3] => Array
(
[ArticleID] => 147970
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-22 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[4] => Array
(
[ArticleID] => 147160
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[5] => Array
(
[ArticleID] => 146351
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-08 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[6] => Array
(
[ArticleID] => 145601
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-01 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[7] => Array
(
[ArticleID] => 145284
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2001-12-29 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
AZITHROMYCIN
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1363612
[Title] => Ditch azithromycin in nongonococcal urethritis?
[Summary] => Recent evidence dictates the need to reassess the roles of doxycycline and azithromycin in treating Chlamydia trachomatis nongonococcal urethritis, according to Dr. Michel Janier.
[DatePublished] => 2014-08-31 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 915186
[Title] => Cases of resistant N. gonorrhoeae seen in San Diego
[Summary] => Neisseria gonorrhoeae cases resistant to azithromycin detected in San Diego led the Centers for Disease Control and Prevention to issue a ”Dear Colleague” letter reminding clinicians to limit use of azithromycin monotherapy to treat uncomplicated rectal and genitourinary infections caused by N. gonorrhoeae.
[DatePublished] => 2013-03-03 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[2] => Array
(
[ArticleID] => 901500
[Title] => Federal STD guidelines address shifting susceptibility
[Summary] => Revised gonorrhea treatment regiment and expanded STD prevention recommendation are key features in updated Sexually Transmitted Disease Control and Prevention.
[DatePublished] => 2013-01-27 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[3] => Array
(
[ArticleID] => 147970
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-22 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[4] => Array
(
[ArticleID] => 147160
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[5] => Array
(
[ArticleID] => 146351
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-08 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[6] => Array
(
[ArticleID] => 145601
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-01 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[7] => Array
(
[ArticleID] => 145284
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2001-12-29 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
abtest
January 22, 2002 - 12:00am
January 15, 2002 - 12:00am
January 8, 2002 - 12:00am
January 1, 2002 - 12:00am
December 29, 2001 - 12:00am